Louise Fleming

Predictors of Response to Biologics for Severe Asthma: A Systematic Review and Meta‐Analysis

Patient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma

Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study

Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update

Stratification of asthma by lipidomic profiling of induced sputum supernatant

Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective

Oropharyngeal Microbiota Clusters in Children with Asthma or Wheeze Associate with Allergy, Blood Transcriptomic Immune Pathways, and Exacerbation Risk

Clinical and transcriptomic features of persistent exacerbation‐prone severe asthma in U‐BIOPRED cohort

Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes

Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes

Global Initiative for Asthma Strategy 2021

Biologicals in childhood severe asthma: the European PERMEABLE survey on the<i>status quo</i>

Expert meeting report: towards a joint European roadmap to address the unmet needs and priorities of paediatric asthma patients on biologic therapy

eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy

Instability of sputum molecular phenotypes in U-BIOPRED severe asthma

GINA 2019: a fundamental change in asthma management

IL-17–high asthma with features of a psoriasis immunophenotype

Contribution of airway eosinophils in airway wall remodeling in asthma: Role of <i><scp>MMP</scp>‐10</i> and <i><scp>MET</scp></i>

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation

“T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin

Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis

Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort

Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome

Pathway discovery using transcriptomic profiles in adult-onset severe asthma

Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma

U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics

A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts